Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CBFYX vs. RIDEX: which is better?

Bottom line

CBFYX vs RIDEX: the short answer

CBFYX (Columbia Bond Fund) and RIDEX (Income Fund Of America) are both mutual funds.

CBFYX is cheaper at 0.41% vs 0.61% — a difference of $20 a year per $10,000 invested.

Over five years, RIDEX returned +9.0% a year vs +0.3% for CBFYX (reporting dates differ).

Updated Nov 19, 2026

CBFYX vs RIDEX side by side

CBFYXRIDEX
TypeMutual fundMutual fund
Fund familyColumbia ThreadneedleAmerican Funds (Capital Group)
CategoryCore / Intermediate BondCore / Intermediate Bond
Expense ratio0.41%0.61%
Annual cost per $10k$41$61
10-yr cost on $10k (prospectus)$676$762
Max front load0%0%
12b-1 fee0%0.25%
1-yr return+2.9%+17.7%
5-yr return (annualized)+0.3%+9.0%
10-yr return (annualized)+1.8%+8.6%
Best quarter—+10.3%
Worst quarter—−16.2%
Net assets (fund)—$148.3B
Number of holdings—3,344
Portfolio turnover228%77%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CBFYX and RIDEX share none of their top holdings.

CBFYX top 10

    RIDEX top 10

    1. Capital Group Central Cash Fund — 4.88%
    2. Philip Morris International Inc — 2.39%
    3. Amgen Inc — 2.02%
    4. Eog Resources Inc — 1.85%
    5. Cvs Health Corp — 1.67%
    6. Unitedhealth Group Inc — 1.57%
    7. Abbvie Inc — 1.45%
    8. Gilead Sciences Inc — 1.36%
    9. Southern Co/the — 1.30%
    10. Canadian Natural Resources Ltd — 1.29%

    FAQ

    What is the difference between CBFYX and RIDEX?
    CBFYX (Columbia Bond Fund) and RIDEX (Income Fund Of America) are both mutual funds. CBFYX is cheaper at 0.41% vs 0.61% — a difference of $20 a year per $10,000 invested.
    Which is cheaper, CBFYX or RIDEX?
    CBFYX has the lower expense ratio (0.41%).
    Should I own both CBFYX and RIDEX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.